Skip to content

Public FDA record

Z-0261-2025: Ambu VivaSight 2 DLT Endobronchial tube, 35 FR (Catalog Number 412351000), 37 Fr (Catalog Number 41237100

Recall record Z-0261-2025 for Ambu Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0261-2025
Company in FDA record
Ambu Inc.
FDA classification date
Oct 30, 2024
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Ambu has received complaints on Ambu VivaSight 2 DLTs regarding hyper angulation of the distal end. The hyper angulation can lead to an increased risk of complications during intubation and potential airway injury.

Source facts

Action
An Urgent Medical Device Correction letter dated 9/24/24 was sent to customers. Advise on actions to be taken by user: Our records indicates that your facility has purchased the Ambu VivaSight 2 DLT products and you may have affected devices in your stock. Please identify if any of your in stock Ambu VivaSight 2 DLT products falls within the affected expiration date and lot numbers range listed on page 1 of this Field Safety Notice. If so, you must visually inspect these products as per below graphics before use to ensure that the distal end is not hyper-angulated. 1. View the blue tip of the Vivasight 2. This can be done without taking the product out of the pouch. 2. Compare the angle (bend) of the tip with the pictures shown above. 3. The bend in the tip should be as shown like in Pictures 1 to 3. 4. If the bend is determined to be similar to Pictures 4, 5 or 6, they should not be used. If hyper-angulation is identified, you must discard the impacted Ambu VivaSight 2 DLT product. If your facility prefers not to inspect affected products and would like to return them, please indicate that on Appendix 1. Ambu will issue RMA Number for your return. Ambu will compensate you by either replacing the units with a new Ambu VivaSight 2 DLT, an aScope 4 broncho slim, which can be used with a conventional DLT or providing a credit. Please note that Ambu VivaSight 2 DLT products shipped from Ambu after September 04, 2024, should not be considered affected. Please return your confirmation of the actions described in the Field Safety Notice (Appendix 1) within 2 weeks of receipt of this letter. Transmission of this Field Safety Notice: This notice needs to be passed on to all those who need to be aware within your organization and/or to any organization where the devices could have been transferred/shipped. Please forward this notice to other organizations on which this action may have an impact. Also, please maintain awareness on this notice and resulting action f
Initiated
2024-09-16
Root cause
Under Investigation by firm
Distribution
US Nationwide. Canada.
Recall number
Z-0261-2025
Recall status
Open, Classified
CDRH record ID
210322
FDA classified
2024-10-30
Recall event number
95454

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗